Role of neurotrophic and growth factors in the rapid and sustained antidepressant actions of ketamine
Authors:
- 17 November 2022
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 224, 109335
Abstract
No abstract availableKeywords
This publication has 169 references indexed in Scilit:
- Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On TrialBiological Psychiatry, 2012
- Brain-Derived Neurotrophic Factor Val66Met Allele Impairs Basal and Ketamine-Stimulated Synaptogenesis in Prefrontal CortexBiological Psychiatry, 2012
- Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress ExposureBiological Psychiatry, 2011
- Effect of brain‐derived neurotrophic factor haploinsufficiency on stress‐induced remodeling of hippocampal neuronsHippocampus, 2011
- A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar DepressionArchives of General Psychiatry, 2010
- Knockdown of brain-derived neurotrophic factor in specific brain sites precipitates behaviors associated with depression and reduces neurogenesisMolecular Psychiatry, 2009
- Peripheral insulin-like growth factor-I produces antidepressant-like behavior and contributes to the effect of exerciseBehavioural Brain Research, 2009
- TrkB Regulates Hippocampal Neurogenesis and Governs Sensitivity to Antidepressive TreatmentNeuron, 2008
- Selective Loss of Brain-Derived Neurotrophic Factor in the Dentate Gyrus Attenuates Antidepressant EfficacyBiological Psychiatry, 2008
- Prevalence, Severity, and Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey ReplicationArchives of General Psychiatry, 2005